Z-Cube And Yissum Research Development Company Ltd. Sign A Licensing Agreement
Z-Cube Srl, the corporate venture arm of Zambon Company SpA, and Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, announced today that they have entered into a license agreement for Z-Cube to develop and commercialize an innovative nanotechnology drug delivery system for the treatment of pain.
Related Posts
Tags: agreement, company, cube, development, licensing, research, sign, yissum
This entry was posted on Monday, June 1st, 2009 at 8:06 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.



